Navigation Links
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Date:9/13/2011

trointestinal-derived peptide hormone that has also been associated with reducing food intake and has been studied as an anti-obesity agent. These two gastrointestinal peptides (GLP-1 and PYY) are secreted into circulation by neuroendocrine cells (L cells) as part of a natural homeostatic mechanism that senses nutrient transit through the gastrointestinal tract. Such nutrient sensing and related mechanisms are thought to be enhanced as a result of certain types of bariatric surgery for weight loss and control of diabetes.

LX4211 treatment also produced a 50.2 mg/dL adjusted mean decrease from baseline in triglycerides, consistent with the triglyceride reduction observed in the Phase 2a study in type 2 diabetics.  In addition, LX4211, compared to placebo, produced a significant adjusted mean decrease in serum uric acid (1.52 mg/dL from baseline to last study visit, p=0.005). Serum uric acid is an emerging marker for cardiovascular risk and renal disease.  These data, together with a trend of improved blood pressure observed in the Phase 2a study, demonstrate that LX4211 has effects on multiple cardiovascular and metabolic risk factors.  Also of importance in this study was the safety of LX4211, which showed no hypoglycemia and no abdominal pain or diarrhea, consistent with the favorable safety profile associated with dual inhibition of SGLT1 and SGLT2 by LX4211 in previous clinical trials. Enrollment in Lexicon's ongoing Phase 2b study of LX4211 in patients with type 2 diabetes is on schedule, with results anticipated in the first half of 2012.

"We have now observed results from several clinical studies of LX4211 which consistently support the concept of dual SGLT1/SGLT2 inhibition for the treatment of diabetes and indicate a long-term opportunity in diabetes prevention," said Pablo Lapuerta, M.D., senior vice president of clinical development and chief medical officer. "The favorab
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
2. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
3. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
4. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  Paper Pak ... has developed APLS ® Body Guard Bio, ... the spread of bacteria and virus while protecting ... Body Guard Bio features a rugged, external nylon ... that create a leak-proof inner chamber that contains ...
(Date:10/22/2014)... Oct. 22, 2014  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... Chief Executive Officer, has been elected to the Company,s ... Steven G. Anderson , Executive Chairman of CryoLife, stated, ... to be an excellent leader who is well positioned ...
(Date:10/22/2014)... 21, 2014   BioNano Genomics , the ... research centers to purchase an Irys™ System . ... Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) and ... obtaining a comprehensive view of a genome was ... does not deliver the scalability or reliability to ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
... Cancer treatment experts today reported their experiences with early ... Systems (NYSE: VAR ), aimed at increasing ... Clinicians from the first two European hospitals to start ... University Hospital in Switzerland and VU University Medical Center ...
... Waters Corporation (NYSE: WAT ) today introduced ... approach for the removal of phospholipids from biological samples. ... liquid-liquid extraction (LLE) methods, Ostro removes up to 30 ... as a major cause of matrix effects in the ...
Cached Medicine Technology:Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments 2Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments 3Waters Introduces Ostro Sample Preparation Products 2
(Date:10/25/2014)... safe and sound is one of the best Halloween treats ... and goody bags have reflective strips that improve visibility to ... Meadowlands Hospital Medical Center in Secaucus, N.J. Trick-or-treaters ... Davis said. He offers these others tips: ... small area of skin first to ensure it doesn,t cause ...
(Date:10/25/2014)... October 25, 2014 Market ... Diagnostics Industry, 2009-2019 is a professional and ... Molecular Diagnostics industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Molecular Diagnostics listing their product ...
(Date:10/25/2014)... October 25, 2014 Limbkeepers® announced today ... of Innovations with Ed Begley Jr, airing 1st QTR ... , In this episode, Innovations will focus on Limbkeepers® ... protect fragile, thinning skin on arms, hands, and legs ... about these versatile products, which help reduce injuries, allow ...
(Date:10/25/2014)... A large influx of international aid is needed, and ... thousands of deaths from the widening Ebola crisis, a ... a specially designed mathematical model, the researchers looked at ... densely populated county of hard-hit Liberia -- Montserrado County, ... researchers said that if international aid isn,t delivered to ...
(Date:10/22/2014)... 22, 2014 On Saturday, October 25, 2014, ... annual family health and fitness fair ¡Vive tu vida! Get ... and good nutrition for better health and wellness for people ... free and open to the public, will be held at ... 9:00 am to 1:00 pm. , “¡Vive tu Vida! ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... - Scientists from the Hebrew University have identified the molecular ... findings of this research have just been published in the ... the entire genetic information required for building the proteins of ... to changes in the cell function. These changes can lead ...
... of the brain,s master circadian clock known as the ... of rhythmic neural activity begins to decline by middle age. ... may have implications for the large number of older people ... "Aging has a profound effect on circadian timing," ...
... , TUESDAY, July 19 (HealthDay News) -- Following up ... for a long time have more gray matter in their ... shrink less as they age and they have stronger connections ... may better relay electrical signals, researchers said. "Our results ...
... triggering another, but explanations for that phenomenon have proved ... first neurobiological evidence that memories formed in the same ... episodic memory. The research was conducted by professor ... School of Arts and Sciences and graduate student Jeremy ...
... By Serena Gordon HealthDay Reporter , MONDAY, July 18 ... ride in a car driven by grandparents because they believe the ... But, new research suggests that children are actually safer in auto ... parent. As a matter of fact, the odds of ...
... , MONDAY, July 18 (HealthDay News) -- Melanoma, the ... by patients themselves, but new research reveals that self-detection ... In the study, conducted by researchers at Memorial ... found that in addition to higher rates of physician-detected ...
Cached Medicine News:Health News:Hebrew U. scientists identify molecular basis for DNA breakage 2Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 2Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 3Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 4Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 5Health News:Does Meditation Boost Brain Health? 2Health News:Penn researchers find neural signature of 'mental time travel' 2Health News:Kids Fare Better in Crashes When Grandparents Driving: Study 2Health News:Kids Fare Better in Crashes When Grandparents Driving: Study 3Health News:Specialists More Likely to Spot Deadly Skin Cancer 2
... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ...
... 2000 assays are designed ... IMMULITE 2000, a high-throughput, ... analyzer. IMMULITE 2000 offers ... and a rapidly expanding ...
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Inquire...
Medicine Products: